Vespyra | One clinician. A full panel. No operational drag.
Care delivery infrastructure

One clinician. A full patient panel. No operational drag.

Vespyra lets independent clinicians run proactive, high-touch care at scale — by turning spoken decisions into finished work, automatically.

For independent clinicians running direct-pay, longitudinal care — in menopause or beyond.

The clinician speaks. Vespyra does the rest. Documentation · patient messages · follow-up · reminders · symptom tracking — handled.
The problem

Proactive care doesn't scale, because the busywork doesn't.

Direct-pay practices have great economics — recurring revenue, no insurance overhead, transparent pricing. But every patient touch still means a clinician manually documenting, messaging, scheduling, and tracking. That cap on capacity is the whole problem.

15–30 min

Lost per patient touch

Documenting, messaging, scheduling, and tracking — repeated across every interaction, every day.

Hire or cap

The only two options

To grow, a clinician adds support staff that erodes margin — or stops taking patients. Both stall the model.

Patients wait

Access stays limited

When capacity depends on manual workflows, patients who need proactive care can't get in.

What we do

One decision. One workflow. No scattered follow-up.

A patient update comes in. Here's what happens next — without Vespyra, and with it.

Typical clinic — 7 manual steps
01Patient update received
02Clinician reviews the chart
03Writes the note
04Writes the patient message
05Sets a reminder
06Updates the tracker
07Checks back later — did follow-up happen?
With Vespyra — 1 decision
01Patient update received
Clinician makes the care decision — out loud.
Vespyra organizes everything downstream
Note written
Patient plan sent
Tracker updated
Reassessment scheduled
Follow-up tracked between visits
The clinician makes the call. The busywork is already handled.
What took 15–30 minutes across tools becomes one structured workflow.
What Vespyra is

The platform proactive care runs on.

Vespyra is the care-delivery platform a clinician runs their proactive practice on. One spoken care decision becomes the finished downstream work — so the clinician makes the call, and Vespyra handles everything after it.

One platform for the whole proactive-care workflow.

A spoken decision becomes the drafted note, the patient plan, the scheduled reassessment, and the tracked follow-up — handled in one place, so nothing scatters across tools and nothing falls through between visits. The clinician makes the call; Vespyra runs the rest of the work.

You make every clinical decision. Vespyra does the work after the decision — it never practices medicine.
HIPAA-aligned. Patient data handled under signed BAAs, on a compliant, standards-based foundation.
What the platform runs
Clinical record & chart note
Patient messaging & care plan
Intake & symptom trackers
Reassessment & follow-up scheduling
One platform — not a pile of disconnected tools.
One decision, shown

Watch one sentence become finished work.

Not a description of what Vespyra does — the actual output. One spoken decision, and everything below is written, sent, logged, and scheduled.

The clinician says
"Margaret's hot flashes are getting worse again and waking her at night. Increase estradiol to 0.075, continue progesterone, and reassess in four weeks."
Vespyra produces all of this — clinician reviews, then it goes out
Chart note · drafted
S: Worsening vasomotor symptoms — daytime hot flashes increased, night sweats disrupting sleep, ~2 wks.
A: Inadequate vasomotor control on current estradiol dose. Progesterone tolerated, adequate.
P: ↑ estradiol 0.05 → 0.075 mg/day. Continue progesterone 100 mg nightly. Reassess 4 wks; advise pt to report no improvement or new symptoms sooner.
Patient message · drafted
To Margaret · async portal
Sorry the hot flashes and night sweats are ramping back up — that usually means your estrogen dose needs a small bump, which is common as things shift. I'm raising your estradiol and keeping progesterone the same. Give it about 4 weeks to settle and we'll reassess — message me sooner if there's no improvement or anything new comes up.
Symptom & dose tracker · logged
Hot flashes
Worsening — day + night
Sleep
Disrupted by night sweats
Estradiol
0.05 → 0.075 mg
Progesterone
100 mg · unchanged
Reassessment · scheduled
4wks
Margaret B. — VMS dose-response check Auto-reminder set · flagged to revisit hot flash control
One sentence in. Four finished work products out.
How it works

The clinician decides. Vespyra carries the rest.

Care is asynchronous by design — and not for convenience. For longitudinal, symptom-based conditions, acting on the full picture over time is better medicine than a 15-minute synchronous snapshot. Patients report between visits; the clinician acts on the complete trajectory on their own schedule; Vespyra carries the coordination. It also happens to be what lets one clinician hold a full panel — because clinician time is no longer capped by the appointment slot.

01 — Data flows in

Patients report, structured

Intake forms and symptom trackers turn scattered patient recall into longitudinal data the clinician can act on.

02 — Clinician speaks

One natural command

"Increase estradiol, continue progesterone, reassess in four weeks." That's the entire input.

03 — Work gets done

Downstream, automatically

Chart, note, patient plan, reminder, tracker, and follow-up — all generated, sent, and tracked between visits.

Validated in production

Not a prototype. A clinic that runs on it today.

Vespyra was built inside The Menopause Clinic — Louisiana's first telehealth clinic dedicated to perimenopause and menopause care — and has run it for a year.

100+

Active members, one clinician

93%

Member retention

96%

Report meaningful improvement

$0

Paid acquisition

1 yr

Profitable, lean operating model

Why now

The need is exploding. The supply isn't.

Menopause care is one of the most underserved markets in medicine — enormous demand, almost no trained supply, and a direct-pay model already proving that patients will pay for care that works. That's the gap Vespyra is built to scale into.

2M

US women enter menopause every year

~1,300

Certified menopause practitioners in the entire country

<1%

Of licensed US doctors are certified in menopause care

Projected market growth by 2030 — to roughly $40B

The direct-pay model is how this gap closes — transparent pricing, no insurance overhead, and the retention and satisfaction that prove patients will pay for proactive care.

But that model is capped by manual work — every patient touch still costs a clinician 15–30 minutes. Vespyra is the infrastructure that lifts the cap, so one clinician can meet far more of the demand without building a team to do it.

Sources: The Menopause Society; Boston Consulting Group, Closing the Menopause Care Gap, 2025.

Where it goes next

Built for menopause. Generalizes to protocol-driven chronic care.

Vespyra was proven in menopause because that care is longitudinal, symptom-based, education-heavy, and protocol-driven. The same infrastructure fits any condition with that shape — each new one adds clinical content to the platform, not a new build.

Endocrine & metabolic

Thyroid, diabetes, metabolic care

Protocol-driven, lab-tracked, and adjusted continuously between visits.

Women's chronic

PCOS, endometriosis, fertility

Clinically adjacent to menopause — the natural next verticals.

Other longitudinal

Hypertension, autoimmune, GI*

Any chronic condition managed proactively over time, not in episodic visits.

* Some conditions benefit from additional remote monitoring. Vespyra is designed to work alongside those tools for comprehensive longitudinal care.

Founder-built

Built by the clinician who needed it.

Crystal Burke, FNP-C, MSCP

Founder and Clinical Director of The Menopause Clinic. Built the production platform end-to-end while running the clinic on it daily — because nothing else could support proactive longitudinal care.

Steven Youngblood, MD

Clinical advisor. Advises on condition modules, medical content, and literature alignment as Vespyra expands across women's chronic conditions.

© 2026 Vespyra
Care delivery infrastructure